Clinical Trial

Effectiveness of Phenazopyridine for Pain Following Urodynamics

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of the study is to determine if taking phenazopyridine (AZO) at the time of urodynamic study testing will decrease pain experienced by patients after undergoing urodynamic testing.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-08-26; most recent amendment 2026-04-23.
Status change: Recruiting → Active, Not Recruiting 2026-04-23
Status change: Not Yet Recruiting → Recruiting 2025-04-10
Trial Details
NCT Number NCT06577493
Lead Sponsor University of South Florida
Conditions Pain After Urodynamic Testing
Enrollment 66 participants
Start Date 2024-12-17
Primary Completion 2025-11-24 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-29